Free Trial

Growth Stocks To Follow Today - June 23rd

Circle Internet Group logo with Finance background

Circle Internet Group, Novo Nordisk A/S, BlackRock, Blueprint Medicines, Welltower, Blackstone, and Apollo Global Management are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings at an above-average rate, often reinvesting profits into research, development or market expansion rather than paying out high dividends. Investors are willing to pay a premium for these names in anticipation of future capital appreciation, which also makes growth stocks more volatile if the companies fail to meet lofty growth targets. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Circle Internet Group (CRCL)

Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

CRCL traded up $18.39 during trading on Monday, hitting $258.67. 68,306,211 shares of the company's stock were exchanged, compared to its average volume of 45,446,723. Circle Internet Group has a 1 year low of $64.00 and a 1 year high of $298.99. The company has a market cap of $57.56 billion and a P/E ratio of -20,441.76.

Read Our Latest Research Report on CRCL

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Novo Nordisk A/S stock traded down $4.87 during trading on Monday, reaching $68.90. 10,694,236 shares of the company's stock were exchanged, compared to its average volume of 7,129,562. Novo Nordisk A/S has a 52-week low of $57.00 and a 52-week high of $148.15. The company has a quick ratio of 0.56, a current ratio of 0.74 and a debt-to-equity ratio of 0.70. The company's 50-day moving average is $68.41 and its two-hundred day moving average is $78.27.

Read Our Latest Research Report on NVO

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of BLK stock traded down $4.76 during trading hours on Monday, reaching $969.68. The company had a trading volume of 273,315 shares, compared to its average volume of 689,942. The stock's fifty day simple moving average is $948.55 and its 200 day simple moving average is $969.40. The company has a market capitalization of $150.23 billion, a P/E ratio of 23.58, a price-to-earnings-growth ratio of 2.96 and a beta of 1.41. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.34 and a current ratio of 4.34. BlackRock has a twelve month low of $773.74 and a twelve month high of $1,084.22.

Read Our Latest Research Report on BLK

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.

Shares of BPMC remained flat at $128.20 during mid-day trading on Monday. 1,870,512 shares of the stock were exchanged, compared to its average volume of 1,261,379. The firm has a 50-day moving average of $104.75 and a two-hundred day moving average of $98.16. Blueprint Medicines has a 12 month low of $73.04 and a 12 month high of $128.34. The company has a current ratio of 2.80, a quick ratio of 2.75 and a debt-to-equity ratio of 1.01. The stock has a market cap of $8.28 billion, a price-to-earnings ratio of -51.89 and a beta of 0.84.

Read Our Latest Research Report on BPMC

Welltower (WELL)

Welltower Inc. NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

WELL stock traded up $2.50 during trading on Monday, reaching $153.74. The stock had a trading volume of 1,058,256 shares, compared to its average volume of 2,911,971. The firm has a fifty day moving average price of $149.79 and a 200 day moving average price of $142.96. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $100.54 billion, a P/E ratio of 88.36, a PEG ratio of 1.76 and a beta of 0.94. Welltower has a 1-year low of $100.13 and a 1-year high of $158.55.

Read Our Latest Research Report on WELL

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Shares of Blackstone stock traded down $2.85 on Monday, hitting $134.84. 1,106,218 shares of the company's stock traded hands, compared to its average volume of 3,797,732. The stock has a market cap of $98.39 billion, a P/E ratio of 40.66, a PEG ratio of 1.26 and a beta of 1.65. The firm's 50-day moving average is $137.23 and its 200 day moving average is $153.63. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.67. Blackstone has a 52-week low of $115.66 and a 52-week high of $200.96.

Read Our Latest Research Report on BX

Apollo Global Management (APO)

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.

APO stock traded down $4.59 during mid-day trading on Monday, hitting $129.93. 989,620 shares of the company were exchanged, compared to its average volume of 3,948,443. The firm has a fifty day simple moving average of $133.31 and a 200 day simple moving average of $146.96. The company has a market capitalization of $74.25 billion, a PE ratio of 22.80, a price-to-earnings-growth ratio of 1.39 and a beta of 1.59. Apollo Global Management has a twelve month low of $95.11 and a twelve month high of $189.49. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.34.

Read Our Latest Research Report on APO

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Circle Internet Group Right Now?

Before you consider Circle Internet Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Circle Internet Group wasn't on the list.

While Circle Internet Group currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines